MYP_103875
Basic Information
T21N17
Antimicrobial
Antiviral
Antiviral Anti-HIV Anti-HIV-1
Antiviral Antiviral mechanism Viral fusion inhibition
Standard
38 amino acids
C210H354N64O56
Standard
Sequence
RIQQIEQKIHHIEQRIQQIEQLLQLTVWGIKQLQARIL
Physicochemical Analysis
4671.45 Da
9.98
1.94
1.63
0.0511
-0.37
0.62
-0.07
103.59
143.68
0.0263
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
2013.94
-14.42
67.0
60.0
168.0
330.0
4.0
47.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0207245 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
HIV-1
RECORD: Rec_0310145 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
None
Disulfide bond(s) reported
Bio-Activity Profile
Antimicrobial Antiviral
HIV-1(human immunodeficiency virus 1):inhiition of cell-cell fusion between TZM-bl cells and HL2/3 cells
0.251±0.0411 μM
IC50
RECORD: Rec_0341415 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
None
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 (human immunodeficiency virus 1) | TZM-bl cells; HL2/3 cells
0.251±0.0411 μM
IC50
Mammalian: 1 h; Yeast: 2 min; E. coli: 2 min